Weiss Asset Management LP purchased a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 32,879 shares of the company's stock, valued at approximately $2,292,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SOLV. Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum during the 2nd quarter valued at about $25,000. Hollencrest Capital Management bought a new stake in Solventum in the second quarter worth approximately $25,000. Richard W. Paul & Associates LLC acquired a new position in shares of Solventum during the 2nd quarter worth $26,000. Family Firm Inc. bought a new position in shares of Solventum during the 2nd quarter valued at $26,000. Finally, Copeland Capital Management LLC acquired a new stake in shares of Solventum in the 3rd quarter valued at $26,000.
Wall Street Analyst Weigh In
Several equities analysts have commented on SOLV shares. BTIG Research began coverage on shares of Solventum in a research report on Thursday, September 5th. They set a "neutral" rating on the stock. Morgan Stanley increased their price objective on Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a report on Monday, November 11th. Mizuho began coverage on Solventum in a report on Wednesday. They issued a "neutral" rating and a $70.00 target price for the company. Wolfe Research initiated coverage on Solventum in a report on Thursday, September 26th. They set a "peer perform" rating on the stock. Finally, Piper Sandler boosted their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $68.29.
Get Our Latest Analysis on SOLV
Solventum Trading Up 0.6 %
Shares of SOLV stock traded up $0.39 during trading hours on Friday, reaching $69.96. 1,049,486 shares of the company's stock were exchanged, compared to its average volume of 1,002,431. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The business has a fifty day moving average price of $70.69 and a 200-day moving average price of $62.88.
Solventum Company Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.